PHARMACOEPIDEMIOLOGICAL MONITORING OF ANTIDEPRESSANT USAGE IN PATIENTS WITH ANXIOUS AND DEPRESSIVE SYNDROMES IN INTERNAL MEDICINE
Aim. To study antidepressant usage in treatment of anxious and depressive disorders in real internal medicine practice.Material and methods. Retrospective analysis of 290 charts of patients, which were observed in Pskov region hospital from 2004 to 2005 was held. All patients suffered from different...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/451 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849227902187470848 |
|---|---|
| author | N. V. Ivanova B. B. Fischman G. I. Schwartsman L. A. Fomenko A. A. Abdulin M. S. Kazymov I. V. Samsonova M. A. Bobyr |
| author_facet | N. V. Ivanova B. B. Fischman G. I. Schwartsman L. A. Fomenko A. A. Abdulin M. S. Kazymov I. V. Samsonova M. A. Bobyr |
| author_sort | N. V. Ivanova |
| collection | DOAJ |
| description | Aim. To study antidepressant usage in treatment of anxious and depressive disorders in real internal medicine practice.Material and methods. Retrospective analysis of 290 charts of patients, which were observed in Pskov region hospital from 2004 to 2005 was held. All patients suffered from different internal diseases and were treated with antidepressants because of anxious and depressive concomitant disorders.Results. Arterial hypertension observed in 28% of patients, ischemic heart disease – in 20%, heart failure – in 14%, cerebrovascular and peripheral nervous system diseases – in 18% and gastroduodenal diseases – in 20% of patients. Amitriptyline took the first place (49%) among antidepressant prescriptions. Next antidepressants according to prescription popularity were paroxetine (22%) and tianeptine (12%). Rate of other antidepressant prescriptions were not higher than 5%. There were differences in antidepressant prescriptions between physicians of different specialties.Conclusion. Reasonable approaches should be used to choose antidepressants. Selective serotonin reuptake inhibitors have benefit for the therapy of concomitant anxious and depressive disorders due to their good tolerability. Nevertheless tricyclic antidepressants are essential in some clinical situations. |
| format | Article |
| id | doaj-art-dd4e055553e84cac8dd29e77894a555c |
| institution | Kabale University |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2015-12-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-dd4e055553e84cac8dd29e77894a555c2025-08-23T10:00:20ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-01336910.20996/1819-6446-2007-3-3-6-9451PHARMACOEPIDEMIOLOGICAL MONITORING OF ANTIDEPRESSANT USAGE IN PATIENTS WITH ANXIOUS AND DEPRESSIVE SYNDROMES IN INTERNAL MEDICINEN. V. Ivanova0B. B. Fischman1G. I. Schwartsman2L. A. Fomenko3A. A. Abdulin4M. S. Kazymov5I. V. Samsonova6M. A. Bobyr7St. Petersburg Medical Academy of postgraduate education; St. Petersburg State Medical Academy named after I.I. Mechnikov; Novgorod State University named after Jaroslaw the WiseSt. Petersburg Medical Academy of postgraduate education; St. Petersburg State Medical Academy named after I.I. Mechnikov; Novgorod State University named after Jaroslaw the WiseSt. Petersburg Medical Academy of postgraduate education; St. Petersburg State Medical Academy named after I.I. Mechnikov; Novgorod State University named after Jaroslaw the WiseSt. Petersburg Medical Academy of postgraduate education; St. Petersburg State Medical Academy named after I.I. Mechnikov; Novgorod State University named after Jaroslaw the WiseSt. Petersburg Medical Academy of postgraduate education; St. Petersburg State Medical Academy named after I.I. Mechnikov; Novgorod State University named after Jaroslaw the WiseSt. Petersburg Medical Academy of postgraduate education; St. Petersburg State Medical Academy named after I.I. Mechnikov; Novgorod State University named after Jaroslaw the WiseSt. Petersburg Medical Academy of postgraduate education; St. Petersburg State Medical Academy named after I.I. Mechnikov; Novgorod State University named after Jaroslaw the WiseSt. Petersburg Medical Academy of postgraduate education; St. Petersburg State Medical Academy named after I.I. Mechnikov; Novgorod State University named after Jaroslaw the WiseAim. To study antidepressant usage in treatment of anxious and depressive disorders in real internal medicine practice.Material and methods. Retrospective analysis of 290 charts of patients, which were observed in Pskov region hospital from 2004 to 2005 was held. All patients suffered from different internal diseases and were treated with antidepressants because of anxious and depressive concomitant disorders.Results. Arterial hypertension observed in 28% of patients, ischemic heart disease – in 20%, heart failure – in 14%, cerebrovascular and peripheral nervous system diseases – in 18% and gastroduodenal diseases – in 20% of patients. Amitriptyline took the first place (49%) among antidepressant prescriptions. Next antidepressants according to prescription popularity were paroxetine (22%) and tianeptine (12%). Rate of other antidepressant prescriptions were not higher than 5%. There were differences in antidepressant prescriptions between physicians of different specialties.Conclusion. Reasonable approaches should be used to choose antidepressants. Selective serotonin reuptake inhibitors have benefit for the therapy of concomitant anxious and depressive disorders due to their good tolerability. Nevertheless tricyclic antidepressants are essential in some clinical situations.https://www.rpcardio.online/jour/article/view/451comorbidityanxious and depressive disorderspsychopharmacotherapyantidepressants |
| spellingShingle | N. V. Ivanova B. B. Fischman G. I. Schwartsman L. A. Fomenko A. A. Abdulin M. S. Kazymov I. V. Samsonova M. A. Bobyr PHARMACOEPIDEMIOLOGICAL MONITORING OF ANTIDEPRESSANT USAGE IN PATIENTS WITH ANXIOUS AND DEPRESSIVE SYNDROMES IN INTERNAL MEDICINE Рациональная фармакотерапия в кардиологии comorbidity anxious and depressive disorders psychopharmacotherapy antidepressants |
| title | PHARMACOEPIDEMIOLOGICAL MONITORING OF ANTIDEPRESSANT USAGE IN PATIENTS WITH ANXIOUS AND DEPRESSIVE SYNDROMES IN INTERNAL MEDICINE |
| title_full | PHARMACOEPIDEMIOLOGICAL MONITORING OF ANTIDEPRESSANT USAGE IN PATIENTS WITH ANXIOUS AND DEPRESSIVE SYNDROMES IN INTERNAL MEDICINE |
| title_fullStr | PHARMACOEPIDEMIOLOGICAL MONITORING OF ANTIDEPRESSANT USAGE IN PATIENTS WITH ANXIOUS AND DEPRESSIVE SYNDROMES IN INTERNAL MEDICINE |
| title_full_unstemmed | PHARMACOEPIDEMIOLOGICAL MONITORING OF ANTIDEPRESSANT USAGE IN PATIENTS WITH ANXIOUS AND DEPRESSIVE SYNDROMES IN INTERNAL MEDICINE |
| title_short | PHARMACOEPIDEMIOLOGICAL MONITORING OF ANTIDEPRESSANT USAGE IN PATIENTS WITH ANXIOUS AND DEPRESSIVE SYNDROMES IN INTERNAL MEDICINE |
| title_sort | pharmacoepidemiological monitoring of antidepressant usage in patients with anxious and depressive syndromes in internal medicine |
| topic | comorbidity anxious and depressive disorders psychopharmacotherapy antidepressants |
| url | https://www.rpcardio.online/jour/article/view/451 |
| work_keys_str_mv | AT nvivanova pharmacoepidemiologicalmonitoringofantidepressantusageinpatientswithanxiousanddepressivesyndromesininternalmedicine AT bbfischman pharmacoepidemiologicalmonitoringofantidepressantusageinpatientswithanxiousanddepressivesyndromesininternalmedicine AT gischwartsman pharmacoepidemiologicalmonitoringofantidepressantusageinpatientswithanxiousanddepressivesyndromesininternalmedicine AT lafomenko pharmacoepidemiologicalmonitoringofantidepressantusageinpatientswithanxiousanddepressivesyndromesininternalmedicine AT aaabdulin pharmacoepidemiologicalmonitoringofantidepressantusageinpatientswithanxiousanddepressivesyndromesininternalmedicine AT mskazymov pharmacoepidemiologicalmonitoringofantidepressantusageinpatientswithanxiousanddepressivesyndromesininternalmedicine AT ivsamsonova pharmacoepidemiologicalmonitoringofantidepressantusageinpatientswithanxiousanddepressivesyndromesininternalmedicine AT mabobyr pharmacoepidemiologicalmonitoringofantidepressantusageinpatientswithanxiousanddepressivesyndromesininternalmedicine |